Market Place
Sourcing Support
Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals
24 Nov 2021 //
GLOBENEWSWIRE
Supernus strikes $400M+ Adamas buyout, tempering patent cliff
12 Oct 2021 //
FIERCEPHARMA
Supernus and Pacira swoop while their targets are down
11 Oct 2021 //
EVALUATE
Adamas Announces New Employment Inducement Grants
10 Sep 2021 //
BUSINESSWIRE
Adamas to Present at Upcoming September Investor Conferences
30 Aug 2021 //
BUSINESSWIRE
Adamas Announces New Employment Inducement Grant
13 Aug 2021 //
BUSINESSWIRE
Adamas Reports Second Quarter 2021 Financial Results
09 Aug 2021 //
BUSINESSWIRE
Adamas to Announce Second Quarter Financial Results
02 Aug 2021 //
BUSINESS WIRE
Adamas Announces New Employment Inducement Grant
09 Jul 2021 //
BUSINESSWIRE
Adamas to Present at Upcoming William Blair Biotech Focus Conference
07 Jul 2021 //
BUSINESSWIRE
Adamas to Present at Upcoming SVB Leerink CNS Forum
22 Jun 2021 //
BUSINESSWIRE
Adamas Announces New Employment Inducement Grant
11 Jun 2021 //
BUSINESSWIRE
Adamas Announces New Employment Inducement Grant
11 Jun 2021 //
BUSINESSWIRE
Adamas Announces New Employment Inducement Grant
11 Jun 2021 //
BUSINESSWIRE
New Data Supports GOCOVRI as an Important Treatment in Parkinson’s Disease
10 Jun 2021 //
BUSINESSWIRE
Analysis finds Adamas Parkinson`s drug provides motor activity improvements
10 Jun 2021 //
SEEKING ALPHA
New Data Analysis Supports GOCOVRI for Motor Complications for People With PD
10 Jun 2021 //
BUSINESSWIRE
Adamas Launches “Picture More Time” Campaign to Raise Awareness & Understanding
27 Apr 2021 //
BUSINESSWIRE
Adamas Announces Two Presentations for the American Academy of Neurology
16 Apr 2021 //
BUSINESSWIRE
Adamas publishes new data analyses demonstrating GOCOVRI treatmen
29 Mar 2021 //
BUSINESSWIRE
Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering
24 Feb 2021 //
BUSINESSWIRE
Adamas Announces Settlement of Patent Litigation with Zydus
01 Feb 2021 //
BUSINESSWIRE
Adamas` Parkinson`s drug gets US marketing authorisation for second indication
01 Feb 2021 //
PHARMAFILE
Adamas Completes Acquisition of OSMOLEX ER®
05 Jan 2021 //
PRESS RELEASE
Adamas Announces Agreement to Settle Patent Litigation with Osmotica
02 Dec 2020 //
GLOBENEWSWIRE
Adamas appoints new Chief Medical Officer, Adrian Quartel, MD
01 Oct 2020 //
SEEKINGALPHA
Adamas presents new post-hoc Phase 3 data analysis for GOCOVRI®
15 Jul 2020 //
GLOBENEWLSWIRE
Adamas unit entered into amended & restated API supply agreement Moehs Ibérica
07 Oct 2017 //
PRESS RELEASE
